PUBLISHER: Lucintel | PRODUCT CODE: 1386194
PUBLISHER: Lucintel | PRODUCT CODE: 1386194
The future of the global hand-held surgical instrument market looks promising with opportunities in the hospital, clinic, and ambulatory surgical center markets. The global hand-held surgical instrument market is expected to reach an estimated $9.5 billion by 2030 with a CAGR of 7.0% from 2024 to 2030. The major drivers for this market are escalating incidence of long-term health conditions, including cardiovascular, urological, neurological, and infectious ailments, increasing elderly demographic prone to diseases, and rising number of surgical procedures.
A more than 150-page report is developed to help in your business decisions.
The study includes a forecast for the global hand-held surgical instrument by product, application, end use industry, and region.
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies hand-held surgical instrument companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the hand-held surgical instrument companies profiled in this report include-
Lucintel forecasts that forceps will remain the largest segment over the forecast period because it assists in eliminating the requirement to handle small objects with one's hands and reduces the risk of contamination.
Within this market, hospitals will remain the largest segment over the forecast period due to significant volume of cases and preventive surgical procedures being conducted within these environments, along with presence of comprehensive array of surgical instruments and access to highly skilled professionals.
APAC will remain the highest growing region over the forecast period due to rise in population, high incidence of chronic illnesses, and increased consumer purchasing power in the region.
Market Size Estimates: Hand-held surgical instrument market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Hand-held surgical instrument market size by product, application, end use industry, and region in terms of value ($B).
Regional Analysis: Hand-held surgical instrument market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different products, applications, end use industries, and regions for the hand-held surgical instrument market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the hand-held surgical instrument market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Answer: The global hand-held surgical instrument market is expected to reach an estimated $9.5 billion by 2030.
Answer: The global hand-held surgical instrument market is expected to grow with a CAGR of 7.0% from 2024 to 2030.
Answer: The major drivers for this market are escalating incidence of long-term health conditions, including cardiovascular, urological, neurological, and infectious ailments, increasing elderly demographic prone to diseases, and rising number of surgical procedures.
Answer: The future of the hand-held surgical instrument market looks promising with opportunities in the hospital, clinic, and ambulatory surgical center markets.
Answer: Some of the key hand-held surgical instrument companies are as follows:
Answer: Lucintel forecasts that forceps will remain the largest segment over the forecast period because it assists in eliminating the requirement to handle small objects with one's hands and reduces the risk of contamination.
Answer: APAC will remain the highest growing region over the forecast period due to rise in population, high incidence of chronic illnesses, and increased consumer purchasing power in the region.
Answer: Yes, Lucintel provides 10% customization without any additional cost.